These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 10329577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
    Rezapkin GV, Alexander W, Dragunsky E, Parker M, Pomeroy K, Asher DM, Chumakov KM.
    Virology; 1998 Jun 05; 245(2):183-7. PubMed ID: 9636357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
    Rezapkin GV, Norwood LP, Taffs RE, Dragunsky EM, Levenbook IS, Chumakov KM.
    Virology; 1995 Aug 20; 211(2):377-84. PubMed ID: 7645242
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I, Nomura T.
    Lab Anim Sci; 1997 Apr 20; 47(2):118-20. PubMed ID: 9150487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M, Abe S, Yoshioka I, Nomoto A.
    Dev Biol Stand; 1993 Apr 20; 78():141-8. PubMed ID: 8388824
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ, Weeks-Levy C, Tatem JM, Gorgacz EJ, Waterfield WF.
    Dev Biol Stand; 1993 Apr 20; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y, Wang H, Zhu S, Li Y, Song L, Liu Y, Liu G, Nishimura Y, Chen L, Yan D, Wang D, An H, Shimizu H, Xu A, Xu W.
    J Gen Virol; 2010 Feb 20; 91(Pt 2):421-9. PubMed ID: 19846676
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
    Dragunsky E, Nomura T, Karpinski K, Furesz J, Wood DJ, Pervikov Y, Abe S, Kurata T, Vanloocke O, Karganova G, Taffs R, Heath A, Ivshina A, Levenbook I.
    Bull World Health Organ; 2003 Feb 20; 81(4):251-60. PubMed ID: 12764491
    [Abstract] [Full Text] [Related]

  • 16. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F.
    Acta Virol; 1996 Jun 20; 40(3):157-70. PubMed ID: 8891097
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J, Levenbook I.
    Acta Microbiol Immunol Hung; 1998 Jun 20; 45(3-4):391-9. PubMed ID: 9873944
    [Abstract] [Full Text] [Related]

  • 19. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
    Rezapkin GV, Douthitt M, Dragunsky E, Chumakov KM.
    Virus Res; 1999 Dec 15; 65(2):111-9. PubMed ID: 10581384
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.